Anti-inflammatory effects of Lactobacillus reuteri LM1071 via MAP kinase pathway in IL-1β-induced HT-29 cells

• Main Authors: Tae-rahk Kim, Kyoung-sook Choi, Yosep Ji, Wilhelm H. Holzapfel, Min-Gyu Jeon
• Format: Article
• Language: English
• Published: Korean Society of Animal Sciences and Technology 2020-11-01
• Series: Journal of Animal Science and Technology
• Subjects: probiotics; safety; adhesive; lactobacillus reuteri; human breast milk
• Online Access: http://www.ejast.org/archive/view_article?pid=jast-62-6-864
• ISSN: 2672-0191; 2055-0391

Lactic acid bacteria are well-known probiotics, conferring several health benefits. In this study, we isolated lactobacilli from human breast milk and identified Lactobacillus reuteri LM1071 (RR-LM1071) using 16S rDNA sequencing. We tested the hemolytic activity, biogenic amine production, and antibiotic susceptibility of this strain to assess its safety. RR-LM1071 was found to be negative for hemolytic activity and biogenic amine production, as well as was measured in susceptible level for antibiotics in the minimal inhibitory concentration (MIC) test. The adhesive properties of RR-LM1071 were higher than those of LGG in HT-29 cells, and showed a greater hydrophobicity than LGG in hexadecane solvent. Under inflammatory conditions, RR-LM1071 suppressed the mRNA expression of IL-6, TNF-α, and IL-4 produced in IL-1β-induced HT-29 cells. Our results suggest that RR-LM1071 is a safe and valuable probiotic that can be used for the treatment of inflammatory bowel disease.